Commercial

German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health

The projected outcome of this acquisition is a boost in operations and the initiation of collaborations in the country, which is a...

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty payments. The tiered royalty payments...

Oral medication for Covid, Paxlovid boosted in Britain, courtesy of the national trial

Pfizer's COVID-19 immunization and antiviral give little indication of dialing back in the pandemic's third year. The company's oral treatment Paxlovid boost...

Novartis to combine its pharma and oncology operations to save $1 Billion

Novartis has opted for a corporate restructure of operations to aid in cash-saving. This involves the combining of the oncology and pharma...

Insud Pharma and Fresenius Kabi join efforts to grow mAbxience

German Fresenius Kabi to acquire Insud Pharmaceutical’s biotech company mAbxience in a new deal. As per the agreement Kabi will acquire 55%...

Sinopharm and TSB’s Covid-19 antibody treatment is set to hit the Chinese market

The two partners will proceed with distribution of Brii Bio/TSB Therapeutics’ monoclonal antibody (mAb) treatment in China, after stockpiling is complete. TSB...

Acacia Pharmaceutical to be acquired by Eagle Pharma in new deal

Acacia Pharma Group is set to be acquired by Eagle Pharmaceuticals, with all share capital being transferred to Acacia at over €94...

CEO of Ukraine-based Enamine Pharmaceuticals, Andrey Tolmachov calls for support on three-tiers

The Russian invasion of Ukraine last month was castigated by the whole world and by many pharma companies who not only donated...

Latest news

AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19

UK-based startup and British-Swedish pharma giant AstraZeneca have signed a licensing agreement amounting to over $150 million....
- Advertisement -

Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion

United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a...

German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health

The projected outcome of this acquisition is a boost in operations and the initiation of collaborations in...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

What Other Industries Can Learn From Pharmaceutical Marketers

Cookie replacement solutions connecting first-party data to individual ads through universal IDs are coming

FSD Pharma Pivots From Cannabis To COVID-19 Treatment

The company is preparing to undertake their Phase 2 study of PEA used to treat cytokine storms in hospitalized COVID-19 patients.